Strategies of vaccine manufacturers to develop their global manufacturing network

DUBLIN, December 30, 2021 / PRNewswire / – The “Information, trends and growth opportunities on EU COVID-19 vaccines and therapies” the report was added to offer.

This research service provides essential information on the European Union and United Kingdom COVID-19 vaccines and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics under development and looks at the supply chain considerations and requirements to manage distribution. Importantly, the study identifies exploitable growth opportunities for industry participants.

Like United States, the European Union has been criticized for vaccine nationalism, but it is taking action to encourage global access to vaccines. He launched the Team Europe initiative to improve manufacturing and access to vaccines, medicines and health technologies in Africa.

Initiatives such as the EU digital vaccination passport and the UK NHS COVID Pass app will help Europe in a safe reopening and in overcoming to some extent the worrying variants of COVID-19. Although vaccinations are progressing at a rapid rate, factors that will determine the future course of campaigns include political and religious situations, availability of and access to vaccines, and reluctance to immunize especially among population groups. younger.

The low vaccination rate in the Center and Eastern Europe (EEC) fuels another wave of COVID-19, causes healthcare crisis in Bulgaria, Romania and Latvia.

Topics covered include:

  • COVID-19 vaccine and treatment analyzes
  • Strategies of vaccine manufacturers to develop their global manufacturing network
  • Deployment of COVID-19 vaccination
  • The role of digital in the COVID-19 battle
  • The universe of growth opportunities

Main topics covered:

1. Strategic imperatives

2. Highlights on vaccines and therapeutics

  • Regional impact of COVID-19 vaccinations

3. Analysis of growth opportunities

  • Scope of the analysis
  • Growth engines for recovery from the COVID-19 pandemic
  • Growth constraints for recovery from the COVID-19 pandemic

4. Global COVID-19 vaccine R&D landscape

  • COVID-19 vaccine pipeline analysis
  • Overview of the main COVID-19 vaccines authorized worldwide
  • Candidate vaccines selected in phase III

5. Global COVID-19 Therapeutic R&D Landscape

  • Small, key molecules at an advanced stage of development (antivirals and immunomodulators)
  • Key mAbs at an advanced stage of development
  • EU COVID-19 Therapeutic Snapshot

6. Strategies of vaccine manufacturers to develop their global network

  • Pfizer / BioNTech vaccines
  • Modern
  • Oxford / AZ
  • Novavax

7. Deployment of COVID-19 vaccination in the EU

  • Secure capacity
  • Distribution of COVID-19 vaccine doses by manufacturer
  • Percentage of adults fully immunized against COVID-19
  • COVID-19 vaccination doses administered in selected countries
  • Germany – We are approaching the first dose milestone of 70%
  • France – More than 70% of the population fully vaccinated
  • Italy – Achieved the 70% milestone of first dose
  • United Kingdom – First European country to pass 70% first dose milestone
  • Behind the successful deployment in the UK
  • DHL Express hub and gateway model

8. Role of digital technology in the fight against COVID-19

  • Digital technology platforms enabling data management, vaccination and COVID-19 rebound
  • EU COVID-19 Certificate / Health Pass
  • IBM Digital Health Pass

9. Universe of growth opportunities

  • Growth Opportunity 1 – Additional and Booster Doses for Declining Immunity and Emerging Viral Variants
  • Growth Opportunity 2 – Strengthening Domestic Manufacturing for a Leading Global Supply of COVID-19 Vaccine
  • Growth Opportunity 3 – Global Standard Solution to Recognize and Verify Each Country’s COVID-19 Health Passport

Companies mentioned

  • AstraZeneca
  • BioNTech
  • DHL
  • IBM
  • Modern
  • Novavax
  • Oxford
  • Pfizer

For more information on this report, visit

About is the world’s leading source for market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links

Source link

Comments are closed.